The Infectious Diseases Data Observatory (IDDO) is a scientifically independent, multi-disciplinary coalition of the global infectious disease and emerging infections communities. It provides the methods, governance and infrastructure to translate data into evidence that improves outcomes for patients worldwide. Currently, IDDO has eight active areas of research with many more already in development or being scoped for feasibility.
Share data

If you work with clinical, laboratory or epidemiological data and want to share your research or access research data then you are welcome to sign up to the Observatory.

We have platforms for a range of diseases including emerging and neglected infections.

Learn about our approach and governance
Learn about our research themes
What is IDDO?

The Infectious Diseases Data Observatory (IDDO) is a researcher driven network which provides data platforms to capture, share and collaborate on infectious disease related data.

Using years of experience and extensive investment in data tools we provide platforms which are designed for effective data analysis and robust governance.

Find out more about IDDO

COVID-19

Explore our work on COVID-19

Sars cov2 causes covid19
View

Research themes

IDDO enables research-driven responses to major challenges of infectious diseases through development and management of data sharing platforms.

Credit: Wellcome Images
Research themes

Contributing data

Learn more about sharing your data through IDDO

Connected world
Contribute data

Tools and resources

IDDO is committed to providing practical tools and services to support the collection of disease characterisation data and develop quality evidence on optimal treatment and response to emerging infections. 

Credit: MORU
View our resources

News

Prof Sir Nicholas White
i
Prof Sir Nicholas White
News Article
11 Jan 2017
Prof Nicholas White recognised for contributions to global health in UK's New Year's Honours 2017
The Mercury (Hobart, Tasmania 1860-1954), Friday 3 May 1946, p7
i
The Mercury (Hobart, Tasmania 1860-1954), Friday 3 May 1946, p7
News Article
13 Dec 2016
Investment in medicine regulatory authorities key to fighting the 21st Century ‘Third Man’
Credit: DNDi
i
Credit: DNDi
News Article
21 Nov 2016
A harmonised platform for visceral leishmaniasis drug-resistance research
Responsible data sharing at the ASTMH Annual Meeting
News Article
04 Nov 2016
Responsible data sharing at the ASTMH Annual Meeting, 14-17 November
View all news items

Latest publications

Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature

Malaria Journal

Published: 10 Feb 2023

Author(s): Lorenzo Arena, Mazvita Zanamwe, Christine M. Halleux, Verena Carrara, Brian J. Angus, Proochista Ariana, Georgina S. Humphreys, Caitlin Richmond, Kasia Stepniewska, Philippe J. Guérin & Piero L. Olliaro

DOI: https://doi.org/10.1186/s12936-023-04441-5

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis

eLife

Published: 22 Dec 2022

Author(s): James A Watson, Robert J Commons, Joel Tarning, Julie A Simpson, Alejandro Llanos Cuentas, Marcus V G Lacerda, Justin A Green, Gavin C K W Koh, Cindy S Chu, François H Nosten, Richard N Price, Nicholas P J Day, Nicholas J White

DOI: 10.7554/eLife.83433

Environmental DNA as an innovative technique to identify the origins of falsified antimalarial tablets—a pilot study of the pharmabiome

Scientific Reports

Published: 20 Dec 2022

Author(s): Jennifer M. Young, Craig Liddicoat, Kor-jent van Dijk, Patricia Tabernero, Celine Caillet, Nicholas J. White, Adrian Linacre, Jeremy J. Austin & Paul N. Newton

DOI: https://doi.org/10.1038/s41598-022-25196-0

View all publications